August 25, 2020
Takeda Pharmaceutical made the right choice in striking a 242 billion yen deal to divest its Japanese consumer healthcare business to US private equity firm Blackstone Group, CEO Christophe Weber said in a briefing on August 24. The Japanese pharma...read more